Roth Capital Downgrades Spectrum Pharmaceuticals (SPPI) to Neutral
Tweet
Share
E-mailGet Alerts SPPI Hot Sheet
Price: $14.83 +2.28%
Rating Summary:
3 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 0
Rating Summary:
3 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 0
Join SI Premium – FREE
Roth Capital downgraded Spectrum Pharmaceuticals (NASDAQ: SPPI) from Buy to Neutral with a price target of $9.00.
For more ratings news on Spectrum Pharmaceuticals click here and for the rating history of Spectrum Pharmaceuticals click here.
Shares of Spectrum Pharmaceuticals closed at $8.13 yesterday.
For more ratings news on Spectrum Pharmaceuticals click here and for the rating history of Spectrum Pharmaceuticals click here.
Shares of Spectrum Pharmaceuticals closed at $8.13 yesterday.
Create E-mail Alert Related Categories
DowngradesRelated Entities
Roth CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
